Article | August 25, 2021

Digital Transformation In Cell Therapy

Source: Cytiva

By Cytiva


To speed discovery and development and to create production process efficiencies, biopharmaceutical innovators are adopting machine learning, bioinformatics, and automation.

On a recent episode of The Business of Biotech, Dr. Mari Mitrani, co-founder and chief science officer of Organicell, and Dr. Michael Bellio, laboratory director, discussed how the clinical-stage regenerative medicine company has prioritized machine learning since its inception. Discover what they and other biopharmas are aiming to do with machine learning in the future.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online